Patent Application
20100175153
1. Field of the Invention
The field of the invention relates to methods of modulating at least one trait in a plant. In particular, this invention relates to the modulation of traits involved in the ethylene response in a plant, including germination, flower and leaf senescence, fruit ripening, leaf abscission, root nodulation, programmed cell death, and responsiveness to stress and pathogen attack. Also encompassed are transgenic plants produced by the disclosed methods.
2. Background
Ethylene (C2H4) is a gaseous plant hormone that affects myriad developmental processes and fitness responses in plants, such as germination, flower and leaf senescence, fruit ripening, leaf abscission, root nodulation, programmed cell death, and responsiveness to stress and pathogen attack (Johnson, P. R. and Ecker J. R., Annu Rev Genet. 32,227-254, 1998). Another effect of ethylene on plant growth is the so-called triple response of etiolated dicotyledoneous seedlings. This response is characterized by the inhibition of hypocotyl and root cell elongation, radial swelling of the hypocotyl, and exaggerated curvature of the apical hook. Over the past decade, genetic screens based on the triple response phenotype have identified more than a dozen genes involved in the ethylene response in plants. These genes can be divided into three distinct categories: constitutive triple response mutants (eto1, eto2 and eto3, ctr1 and ran1/ctr2); ethylene insensitive mutants (etr1, etr2, ein2, ein3, ein4, ein5, and ein6); and tissue-specific ethylene insensitive mutants (hls1, eir1, and several auxin resistant mutants).
Genetic and molecular analysis of these mutants has defined a largely linear ethylene response pathway ranging from the hormone perception at the membrane to transcriptional regulation in the nucleus. Ethylene is perceived by a family of membrane-associated receptors, including ETR1/ETR2, ERS1/ERS2 and EIN4 in Arabidopsis. Ethylene binds to its receptors via a copper cofactor, and plays a negative role, whereby ethylene binding represses activity of the receptor. In the absence of ethylene, the receptors are hypothesized to be in a functionally active form that constitutively activates a Raf-like serine/threonine kinase, CTR1, also a negative regulator of the pathway. EIN2, EIN3, EIN5, and EIN6 are positive regulators of ethylene responses, acting downstream of CTR1. EIN2 is an integral membrane protein.
Loss-of-function mutations in EIN2 cause complete ethylene insensitivity, indicating that EIN2 is a positive component essential for the ethylene responses. Ethylene signaling downstream of EIN2 is mediated by EIN3, a nuclear protein. The nuclear protein EIN3 is a transcription factor that regulates the expression of its immediate target genes such as ERF1. ERF1 belongs to a large family of AP2 domain-containing transcriptional factors that have been shown to bind to a GCC-box present in the promoters of many ethylene-inducible, defense-related genes. Thus a transcriptional cascade mediated by EIN3/EIL and ERF proteins leads to the regulation of ethylene-controlled gene expression (Wang, K. L., et al. Plant Cell 14 Suppl, S131-151, 2002). The ein3 mutants show a loss of ethylene-mediated effects including gene expression, triple response, cell growth inhibition, and reduced senescence. Conversely, overexpression of EIN3 results in constitutive ethylene responses in both wild-type and ein2 mutant backgrounds. These results demonstrate that EIN3 is both necessary and sufficient for the activation of the ethylene pathway. Biochemical studies revealed that EIN3 protein can bind to a specific sequence in the promoter of a target gene, ERF1 (Solano et al., 1998).
Although EIN3 has been shown to be an essential transcription factor mediating a diverse array of plant responses to ethylene, the mechanism of its activation by ethylene has eluded characterization. Indeed, the mechanism by which genes involved in the ethylene response of plants are regulated is poorly understood. Thus, there is a need for identification of the mechanisms whereby the ethylene response in plants is regulated. Further, there is a need for methods of modulating of the mechanisms regulating the ethylene response to control aspects of the ethylene such as senescence, fruit ripening, the stress response, germination, pathogen resistance, and leaf abscission.
Using a variety of genetic and molecular techniques, the regulation of the EIN3 transcription factor was examined, and a post-transcriptional mechanism for regulating a plant cell's response to ethylene using F-box proteins was elucidated. In particular, the F-box proteins EBF1 and EBF2 were identified as F-box proteins that bind to EIN3 and target the EIN3 protein for degradation through the ubiquitin/proteasome pathway.
Transgenic plants having an altered sensitivity to ethylene are described herein. The plant may include a recombinant nucleic acid sequence that alters the expression of an F-box gene, wherein the F-box gene encodes a first protein that interacts with a second protein wherein said second protein is involved in the ethylene response of the plant. These transgenic plants may have an enhanced sensitivity to ethylene. In some versions of the transgenic plant having an enhanced sensitivity to ethylene, the recombinant nucleic acid sequence disrupts the expression of the F-box gene.
In some versions, the transgenic plant has a reduced sensitivity to ethylene. In versions of the transgenic plant having a reduced sensitivity to ethylene, the recombinant nucleic acid sequence increases the expression of the F-box gene.
The recombinant nucleic acid sequence may include a sequence that hybridizes to the F-box gene under high stringency. The recombinant nucleic acid sequence may encode an F-box protein that encodes a first protein that interacts with a second protein wherein the second protein is involved in the ethylene response of the plant.
The F-box gene may include a polynucleotide sequence that hybridizes to the sequence of SEQ ID NO: 1 under high stringency. The F-box gene may include a polynucleotide sequence that hybridizes to the sequence of SEQ ID NO: 3 under high stringency. The second protein involved in the ethylene response may include a protein having at least 80% identity to SEQ ID NO: 6. In some versions, the second protein includes the EIN3 protein.
In one version, a transgenic plant has an increased sensitivity to ethylene. In this version, the plant may include a recombinant nucleic acid sequence that disrupts the expression of an EBF gene, wherein the EBF gene encodes a protein (e.g., EBF1 and/or EBF2) that interacts with a member of the EIN3/EIL family of transcription factor proteins.
Also described herein are seeds produced from transgenic plants having an altered sensitivity to ethylene. The plants may include a recombinant nucleic acid sequence that alters the expression of an F-box gene, wherein the F-box gene encodes a first protein that interacts with a second protein wherein the second protein is involved in the ethylene response of the plant.
In some versions, the recombinant nucleic acid sequence is operably linked to a promoter. The promoter may be a constitutive promoter or an inducible promoter. The promoter may be a tissue-specific promoter.
In some versions, the plant is chosen from dicotyledons and monocotyledons including but not limited to rice, maize, wheat, barley, sorghum, millet, grass, oats, tomato, potato, banana, kiwi fruit, avocado, melon, mango, cane, sugar beet, tobacco, papaya, peach, strawberry, raspberry, blackberry, blueberry, lettuce, cabbage, cauliflower, onion, broccoli, brussel sprout, cotton, canola, grape, soybean, oil seed rape, asparagus, beans, carrots, cucumbers, eggplant, melons, okra, parsnips, peanuts, peppers, pineapples, squash, sweet potatoes, rye, cantaloupes, peas, pumpkins, sunflowers, spinach, apples, cherries, plums, cranberries, grapefruit, lemons, limes, nectarines, oranges, peaches, pears, tangelos, tangerines, carnation, chrysanthemum, petunia, rose, geranium, violet, gladioli, orchid, lilac, crabapple, sweetgum tree, maple tree, poinsettia, locust tree, oak tree, ash tree and linden tree. The plant may be Arabidopsis thaliana.
Also described herein are plant tissues derived from transgenic plants having an altered sensitivity to ethylene, said plants including a recombinant nucleic acid sequence that alters the expression of an F-box gene, wherein the F-box gene encodes a first protein that interacts with a second protein wherein the second protein is involved in the ethylene response of the plant.
Also described herein are methods of regulating at least one aspect of the ethylene response of a plant including modulating the activity or expression of an F-box protein. In some versions, the ethylene response may be modulated by treating the plant with a compound that modulates the activity or expression of an F-box protein. Treating may include immersing, spraying, powdering, drenching, dripping, or irrigating the plant with the compound.
In some versions, modulating the activity or expression of an F-box protein includes enhancing or inhibiting the binding of an F-box protein to a protein encoded by a gene involved in the ethylene response of the plant. Enhancing or inhibiting the binding of an F-box protein to a protein encoded by a gene involved in the ethylene response may include enhancing or inhibiting the binding of an F-box protein to a transcription factor involved in the ethylene response. Enhancing or inhibiting the binding of an F-box protein to a transcription factor involved in the ethylene response may include enhancing or inhibiting the binding of an F-box protein to a protein having at least 80% identity to SEQ ID NO: 6. Enhancing or inhibiting the binding of an F-box protein to a transcription factor involved in the ethylene response may include enhancing or inhibiting the binding of an F-box protein to an EIN3 protein. Modulating the activity or expression of an F-box protein may include modulating the activity or expression of an F-box protein having at least 80% identity to SEQ ID NO: 2. Modulating the activity or expression of an F-box protein may include modulating the activity or expression of an F-box protein including the sequence shown in SEQ ID NO: 2. Modulating the activity or expression of an F-box protein may include modulating the activity or expression of an F-box protein including at least 80% identity to SEQ ID NO: 4. Modulating the activity or expression of an F-box protein may includes modulating the activity or expression of an F-box protein including the sequence shown in SEQ ID NO: 4.
In some versions, the aspect of the ethylene response that is regulated may be any of: senescence, fruit ripening, fruit drop, the stress response, germination, pathogen resistance, leaf abscission, the triple response in an etiolated seedling, or stability of an EIN3 protein. In one version, the aspect of the ethylene response that is regulated is the stability of a protein having at least 80% identity to SEQ ID NO: 6.
Also described herein are methods of regulating at least one aspect of the ethylene response of a plant including modulating the activity or expression of an EBF protein, such as EBF1 and/or EBF2.
Also described herein is a method of identifying a compound that modulates the ethylene response of a plant including: contacting a plant, part of a plant, or a plant cell with a compound, wherein the plant, part of a plant, or a plant cell expresses a recombinant nucleic acid encoding an F-box protein wherein the F-box protein interacts with a protein involved in the response of the plant to ethylene; detecting the activity or expression of the F-box protein; and comparing the activity or expression of the F-box protein after contacting the plant, part of a plant, or a plant cell with the compound to the activity or expression of the F-box protein in the absence of the compound to identify a compound that modulates the ethylene response of said plant.
In some versions of the method of identifying a compound that modulates the ethylene response of a plant, the F-box protein includes an F-box protein whose expression is influenced by ethylene. The F-box protein may have at least 80% identity to SEQ ID NO: 2. The F-box protein may include the sequence shown in SEQ ID NO: 2. The F-box protein may include proteins having at least 80% identity to SEQ ID NO: 4. The F-box protein may include the sequence shown in SEQ ID NO: 4. The F-box protein may interact with a protein having at least 80% identity to SEQ ID NO: 6. The F-box protein may interact with a protein having the sequence shown in SEQ ID NO: 6.
In some versions, the activity or expression of the F-box protein that is detected and compared includes binding of the F-box protein to a target. The target may include a protein encoded by a gene involved in the ethylene response of the plant. The gene involved in the ethylene response of the plant may include a protein having at least 80% identity to SEQ ID NO: 6.
In one version, the method of identifying a compound that modulates the ethylene response of a plant includes: contacting a plant, part of a plant, or a plant cell with a compound, wherein the plant, part of a plant, or a plant cell expresses a recombinant nucleic acid encoding an EBF protein (e.g., EBF1 and/or EBF2) wherein the EBF protein interacts with a member of the EIN3/EIL family of transcription factors involved in the response of the plant to ethylene; detecting the activity or expression of the EBF protein; and comparing the activity or expression of the EBF protein after contacting the plant, part of a plant, or a plant cell with the compound to the activity or expression of the EBF protein in the absence of the compound to identify a compound that modulates the ethylene response of the plant.
Also described herein are methods of making a transgenic plant having an altered sensitivity to ethylene including: contacting a plant cell with a recombinant nucleic acid that alters the expression of an F-box gene, wherein the F-box gene encodes a first protein that interacts with a second protein involved in the response of the plant to ethylene; and producing a plant from the plant cell.
The plant may be a dicotyledonous plant. The plant may be a monocotyledonous plant. The F-box gene may include a polynucleotide sequence that hybridizes to the sequence of SEQ ID NO: 1 under high stringency. The F-box gene may include a polynucleotide sequence that hybridizes to the sequence of SEQ ID NO: 3 under high stringency. The gene involved in the ethylene response may includes a polynucleotide sequence that hybridizes to the sequence of SEQ ID NO: 5 under high stringency.
In some versions, the recombinant nucleic acid disrupts more than one F-box gene encoding an F-box protein that interacts with a protein encoded by a gene involved in the ethylene response. During the making of a transgenic plant having an altered sensitivity to ethylene, the step of contacting the plant cell with a recombinant nucleic acid may be by physical means. The step of contacting may be by chemical means. The plant cell may be chosen from protoplasts, gamete producing cells, and cells that regenerate into a whole plant.
In one version, the methods of making a transgenic plant having an altered sensitivity to ethylene includes contacting a plant cell with a recombinant nucleic acid that alters the expression of an EBF gene (e.g., EBF1 or EBF2), wherein the EBF gene encodes a first protein that interacts with a member of the EIN3/EIL family of transcription factors involved in the response of the plant to ethylene; and producing a plant from the plant cell. In another format, the methods include detecting the activity or expression of proteins involved in the ethylene response pathway, such as EIN3.
Also described herein is a recombinant nucleic acid sequence including SEQ ID NO: 3. A recombinant nucleic acid sequence hybridizing to SEQ ID NO: 3 under high stringency is also described.
Described herein are transgenic plants having a modified ethylene response, methods of making these transgenic plants, methods of regulating at least one aspect of the ethylene response of a plant, methods of identifying compounds that modulate the ethylene response of a plant, and a recombinant nucleic acid sequence encoding an F-box protein that modulates the ethylene response of a plant by binding to the EIN3 protein.
Embodiments of the invention are based, in part, on the recognition that proteins involved in the ethylene response pathway in plants may be regulated by F-box proteins that may target them for degradation by the ubiquitination/proteosome pathway. In particular, the EIN3 family of transcription factors may be targeted for degradation by F-box proteins such as EBF1 and EBF2 (for EIN3 Binding F-box protein 1 and 2). Experimental and theoretical support for this interaction is provided below. As used herein, unless the context makes it clear otherwise, the term “F-box gene” refers to an F-box gene encoding an F-box protein that interacts with a protein involved in the ethylene response of a plant. EBF proteins include EIN3 binding F-box proteins, such as EBF1 and EBF2 as described herein.
Embodiments of the invention are also based partly upon the identification of an F-box protein gene, EBF2, that is involved in regulating a plant's response to ethylene. Thus, one embodiment of the invention provides isolated nucleic acids including nucleotide sequences including or related to the EBF2 genes and/or encoding polypeptides including or related to the EBF2 proteins. Further, other F-box proteins may also be modulated to regulate a response to ethylene by a plant, including known F-box proteins such as EBF 1. Thus, one embodiment of the invention provides isolated nucleic acids including nucleotide sequences including or related to the EBF1 genes and/or encoding polypeptides including or related to the EBF1 proteins. Although this disclosure specifically describes the EBF1 and EBF2 F-box proteins, other F-box proteins having the characteristics described below may also be used in the methods of the invention.
EBF1 and EBF2 sequences include the specifically disclosed sequences, and splice variants, allelic variants, synonymous sequences, and homologous or orthologous variants thereof. Thus, for example, embodiments of the invention include genomic and cDNA sequences from the EBF1 and EBF2 genes.
Embodiments of the invention also include allelic variants and homologous or orthologous sequences. For example, these variants are useful in allele specific hybridization screening or PCR amplification techniques. Moreover, subsets of the EBF1 and/or EBF2 sequences, including both sense and antisense sequences, and both normal and mutant sequences, as well as intronic, exonic and untranslated sequences, may be employed for these techniques. Such sequences may include a small number of consecutive nucleotides from the sequence disclosed or otherwise enabled herein but preferably include at least 8-10, and more preferably 9-25, consecutive nucleotides from EBF1 and/or EBF2 sequences. Various nucleic acid constructs in which EBF1 and/or EBF2 sequences, either complete or subsets, are operably joined to exogenous sequences to form cloning vectors, expression vectors, fusion vectors, transgenic constructs, and the like are also contemplated.
EBF 1 and EBF2 were shown to modulate the ethylene response in Arabidopsis, as described below. Further, EBF2, and mutants of EBF 1 and EBF2 were identified in Arabidopsis lines. Accordingly, embodiments of the invention include the EBF1 and EBF2 genes and mutations thereof, as well as a characterization of the EBF1 and EBF2 mutants discovered in Arabidopsis. However, the disclosed methods are not limited to any particular plant type. It is expected that similar mutations in other plants will result in similar phenotypes.
Embodiments of the invention also include functional EBF1 and/or EBF2 polypeptides, and functional fragments thereof. As used herein, the term “functional polypeptide” refers to a polypeptide which possesses biological function or activity which is identified through a defined functional assay and which is associated with a particular biologic, morphologic, or phenotypic alteration in the cell. The terms “functional fragments of EBF1 polypeptide”, and “functional fragments of EBF2” refer to all fragments of EBF1 and EBF2 that retain the activity described herein, e.g., ability to modulate the ethylene response of a plant, portion or a plant, or plant cell. Biologically functional fragments, for example, can vary in size from a polypeptide fragment as small as an epitope capable of binding an antibody molecule to a large polypeptide capable of participating in the characteristic induction or programming of phenotypic changes within a cell. The “ethylene response” refers to a plant trait that is mediated by ethylene gas, including but not limited to germination, flower and leaf senescence, fruit ripening, fruit drop, leaf abscission, root nodulation, programmed cell death, responsiveness to stress, responsiveness to pathogen attack, and the “triple response” of etiolated dicotyledoneous seedlings (e.g., inhibition of hypocotyl and root cell elongation, radial swelling of the hypocotyl, and exaggerated curvature of the apical hook).
Ethylene causes developmental changes that result in fruit ripening. New enzymes are made because of the ethylene signal. These include hydrolases to facilitate break down of fruit components, amylases to accelerate hydrolysis of starch into sugar, pectinases to catalyze degradation of pectin, and so on. Ethylene increases the transcription of genes that are then transcribed and translated to make these enzymes. The enzymes then catalyze reactions to alter the characteristics of the fruit.
Enzymes produced as a result of exposure to ethylene facilitate the ripening responses. Chlorophyll is broken down and sometimes new pigments are made so that the fruit skin changes color from green to red, yellow, or blue. Acids are broken down so that the fruit changes from sour to neutral. The degradation of starch by amylase produces sugar. This reduces the mealy (floury) quality and increases juiciness of the fruit. The breakdown of pectin by pectinase results in a softer fruit. Enzymes also break down large organic molecules into volatile smaller molecules which are detected as an aroma.
Fruit drop is related to fruit ripening. The fruit-ripening process described above, also occurs in a layer of cells in the pedicel near the point of attachment to the stem of the plant. This layer of cells in the pedicel is often called the abscission zone because this layer will eventually separate and the fruit will drop from the plant.
The cells in this cross sectional layer in the pedicel receive the ethylene signal from the ripening fruit. Reception of the signal results in the production of new enzymes. The cells “ripen” and pectinases attack the cells of the abscission zone. When the cell connection have been sufficiently weakened, the weight of the fruit will cause it to fall from the plant.
Plant senescence is a genetically programmed process; it is the last phase of plant development and ultimately leads to death. Plant hormones such as ethylene and cytokinins play vital roles in the regulation of senescence.
Many modifications of the EBF1 and/or EBF2 primary amino acid sequence may result in plants having an enhanced sensitivity to ethylene (e.g., ethylene hypersensitivity). In some versions, the modification of the EBF1 and/or EBF2 primary amino acid sequence results in a reduced or eliminated expression of EBF1 and/or EBF2. In some variations, the modification of the EBF1 and/or EBF2 primary amino acid sequence results in a reduced or eliminated binding of EBF1 and/or EBF2 to binding partners (e.g., EIN3, or members of the SCF complex). Such modifications may be deliberate, as by site-directed mutagenesis, or may be spontaneous. All of the polypeptides produced by these modifications are included herein. Further, deletion of one or more amino acids can also result in a modification of the structure of the resultant molecule without significantly altering its activity to affect the ethylene response. Deletions may include 1, 2, 3, 4 or 5 deleted amino acids. Deletions may include 6, 7, 8, 9 or 10 deleted amino acids. Deletions may also include 11, 12, 13, 14 or 15 deleted amino acids. Deletions may also include 16, 17, 18, 19 or 20 deleted amino acids. Deletions may also include 20-25 amino acid deletions, 25-30 amino acid deletions or 35 to 40 amino acid deletions. This can lead to the development of a smaller active molecule which could have broad utility in exhibiting enhanced sensitivity to ethylene (e.g., ethylene hypersensitivity).
Furthermore, some modifications of the EBF1 and/or EBF2 primary amino acid sequence may result in plants having a reduced sensitivity to ethylene (e.g., ethylene insensitivity). In some versions, the modification of the EBF1 and/or EBF2 primary amino acid sequence results in an increased or enhanced expression of EBF1 and/or EBF2. In some variations, the modification of the EBF1 and/or EBF2 primary amino acid sequence results in a increased or enhanced binding of EBF1 and/or EBF2 to binding partners (e.g., EIN3, or members of the SCF complex). Further, deletion of one or more amino acids can also result in a modification of the structure of the resultant molecule without significantly altering its activity to affect the ethylene response. Deletions may include 6, 7, 8, 9 or 10 deleted amino acids. Deletions may also include 11, 12, 13, 14 or 15 deleted amino acids. Deletions may also include 16, 17, 18, 19 or 20 deleted amino acids. Deletions may also include 20-25 amino acid deletions, 25-30 amino acid deletions or 35 to 40 amino acid deletions Such modifications may be deliberate, as by site-directed mutagenesis, or may be spontaneous. All of the polypeptides produced by these modifications are included herein.
EBF1 and EBF2 polypeptides include amino acid sequences substantially the same as the sequence set forth in SEQ ID NO: 2 and SEQ ID NO: 4, respectively, including mutants that result in plants having modified ethylene responses. The term “substantially the same” refers to amino acid sequences that provide nearly the same amino acid sequence and retain the activity of EBF 1 and/or EBF2 as described herein. The EBF 1 and/or EBF2 polypeptides of the invention include conservative variations of the polypeptide sequence.
The term “conservative variation” as used herein denotes the replacement of an amino acid residue by another, biologically similar residue. Examples of conservative variations include the substitution of one hydrophobic residue such as isoleucine, valine, leucine or methionine for another, or the substitution of one polar residue for another, such as the substitution of arginine for lysine, glutamic for aspartic acids, or glutamine for asparagine, and the like. The term “conservative variation” also includes the use of a substituted amino acid in place of an unsubstituted parent amino acid provided the protein retains its ability to alter the ethylene response.
Methods of alignment of sequences for comparison are well known in the art. Various programs and alignment algorithms are described in: Smith and Waterman (1981); Needleman and Wunsch (1970); Pearson and Lipman (1988); Higgins and Sharp (1988); Higgins and Sharp (1989); Corpet et al. (1988); Huang et al. (1992); and Pearson et al. (1994). Altschul et al. (1994) presents a detailed consideration of sequence alignment methods and homology calculations.
The NCBI Basic Local Alignment Search Tool (BLAST) (Altschul et al., 1990) is available from several sources, including the National Center for Biotechnology Information (NCBI, Bethesda, Md.) and on the Internet, for use in connection with the sequence analysis programs blastp, blastn, blastx, tblastn and tblastx. It can be accessed at the NCBI Website. A description of how to determine sequence identity using this program is available at the NCBI website.
Such sequence alignments provide a good indication of the degree of variation of amino acid residues at any given position that may be tolerated. One of skill in the art would understand that highly conserved regions are less likely to tolerate significant variation while less conserved regions are more likely to tolerate variation. Also, one of skill in the art will appreciate that where corresponding residues vary between the sequences, such variation gives an indication of the nature of changes that are likely to be tolerated without disturbing the function of the protein.
EBF1 and/or EBF2 proteins can be analyzed by standard SDS-PAGE and/or immunoprecipitation analysis and/or Western blot analysis, for example. Embodiments of the invention also provide an isolated polynucleotide sequence encoding a polypeptide having the amino acid sequence of SEQ ID NO: 2 or SEQ ID NO: 4. The term “isolated” as used herein includes polynucleotides substantially free of other nucleic acids, proteins, lipids, carbohydrates or other materials with which it is naturally associated. Polynucleotide sequences of the invention include DNA, cDNA and RNA sequences which encode EBF1, EBF2 and EIN3. It is understood that polynucleotides encoding all or varying portions of EBF1 and/or EBF2 are included herein, as long as they encode a polypeptide with some EBF1 and/or EBF2 activity. Such polynucleotides include naturally occurring, synthetic, and intentionally manipulated polynucleotides as well as splice variants. For example, portions of the mRNA sequence may be altered due to alternate RNA splicing patterns or the use of alternate promoters for RNA transcription.
Moreover, EBF1 and/or EBF2 polynucleotides include polynucleotides having alterations in the nucleic acid sequence. For example, EBF1 and/or EBF2 may be altered so that it encodes a polypeptide having the ability to modulate an aspect of the ethylene response, such as germination, flower and leaf senescence, fruit ripening, leaf abscission, root nodulation, programmed cell death, responsiveness to stress, responsiveness to pathogen attack, and the “triple response” of etiolated dicotyledoneous seedlings. Alterations in EBF 1 and/or EBF2 nucleic acids include but are not limited to intragenic mutations (e.g., point mutation, nonsense (stop), antisense, splice site and frameshift) and heterozygous or homozygous deletions. Detection of such alterations can be done by standard methods known to those of skill in the art including sequence analysis, Southern blot analysis, PCR based analyses (e.g., multiplex PCR, sequence tagged sites (STSs)) and in situ hybridization. Embodiments of the invention also include anti-sense polynucleotide sequences.
The polynucleotides described herein include sequences that are degenerate as a result of the genetic code. There are 20 natural amino acids, most of which are specified by more than one codon. Therefore, all degenerate nucleotide sequences are included in the invention, particularly degenerate nucleotide sequences that encode EBF1 and/or EBF2 polypeptides that retain the activity of the EBF1 and/or EBF2 protein. A “functional polynucleotide” denotes a polynucleotide which encodes a functional polypeptide as described herein. In addition, embodiments of the invention also include a polynucleotide encoding a polypeptide having the biological activity of an amino acid sequence of SEQ ID NO: 2 or SEQ ID NO: 4 and retaining the ability to alter the plant's response to ethylene.
As used herein, the terms “polynucleotides” and “nucleic acid sequences” refer to DNA, RNA and cDNA sequences.
The polynucleotides encoding EBF1 and EBF2 include the nucleotide sequences of SEQ ID NO: 1 and SEQ ID NO: 3, respectively. Nucleic acid sequences complementary to SEQ ID NOs: 1 and 3 are also encompassed within the present invention. A complementary sequence may include an antisense nucleotide. When the sequence is RNA, the deoxyribonucleotides A, G, C, and T of SEQ ID NOS: 1 and 3 are replaced by ribonucleotides A, G, C, and U, respectively. Also included in the invention are fragments (“probes”) of the above-described nucleic acid sequences that are at least 15 bases in length, which is sufficient to permit the probe to selectively hybridize to DNA that encodes the protein of SEQ ID NO: 2 or SEQ ID NO: 4.
Nucleic acid sequences complementary to SEQ ID NOs: 1 and 3 are also encompassed within the present invention. A complementary sequence may include an antisense nucleotide. When the sequence is RNA, the deoxyribonucleotides A, G, C, and T of SEQ ID NOS: 1 and 3 are replaced by ribonucleotides A, G, C, and U, respectively. Also included in the invention are fragments (“probes”) of the above-described nucleic acid sequences that are at least 15 bases in length, which is sufficient to permit the probe to selectively hybridize to DNA that encodes the protein of SEQ ID NO: 2 or SEQ ID NO: 4.
“Antisense” nucleic acids are DNA or RNA molecules that are complementary to at least a portion of a specific mRNA molecule (Weintraub, Scientific American 262 40, 1990). In the cell, the antisense nucleic acids hybridize to the corresponding mRNA, forming a double-stranded molecule. This interferes with the translation of the mRNA since the cell will not translate an mRNA that is double-stranded. Antisense oligomers of about 15 nucleotides are preferred, since they are easily synthesized and are less likely to cause non-specific interference with translation than larger molecules. The use of antisense methods to inhibit the in vitro translation of genes is well known in the art (Marcus-Sakura Anal. Biochem. 172: 289, 1998). In the present case, plants transformed with constructs containing antisense fragments of the EBF1 and/or EBF2 genes may display a modulated ethylene response.
Long double-stranded RNAs (dsRNAs; typically >200 nt) can be used to silence the expression of target genes in plants and plant cells. Upon introduction, the long dsRNAs enter the RNA interference (RNAi) pathway which involves the production of short (20-25 nucleotide) small interfering RNAs (siRNAs) and assembly of the siRNAs into RNA-induced silencing complexes (RISCs). The siRNA strands are then unwound to form activated RISCs. which cleave the target RNA. Double stranded RNA has been shown to be extremely effective in silencing a target RNA. Introduction of double stranded RNA corresponding to the EBF1 and/or EBF2 genes would be expected to modify the ethylene response of a plant, part of a plant, or a plant cell, as discussed herein, including, but not limited to, germination, flower and leaf senescence, fruit ripening, leaf abscission, root nodulation, programmed cell death, responsiveness to stress, responsiveness to pathogen attack, and the “triple response” of etiolated dicotyledoneous seedlings.
“Hybridization” refers to the process by which a nucleic acid strand joins with a complementary strand through base pairing. Hybridization reactions can be sensitive and selective so that a particular sequence of interest can be identified even in samples in which it is present at low concentrations. Suitably stringent conditions can be defined by, for example, the concentrations of salt or formamide in the prehybridization and hybridization solutions, or by the hybridization temperature, and are well known in the art. In particular, stringency can be increased by reducing the concentration of salt, increasing the concentration of formamide, or raising the hybridization temperature.
For example, hybridization under high stringency conditions could occur in about 50% formamide at about 37° C. to 42° C. Hybridization could occur under reduced stringency conditions in about 35% to 25% formamide at about 30° C. to 35° C. In particular, hybridization could occur under high stringency conditions at 42° C. in 50% formamide, 5×SSPE, 0.3% SDS, and 200 ng/ml sheared and denatured salmon sperm DNA. Hybridization could occur under medium stringency conditions as described above, but in 35% formamide at a reduced temperature of 35° C. The temperature range corresponding to a particular level of stringency can be further narrowed by calculating the purine to pyrimidine ratio of the nucleic acid of interest and adjusting the temperature accordingly. Variations on the above ranges and conditions are well known in the art. “Selective hybridization” as used herein refers to hybridization under moderately stringent or highly stringent physiological conditions (See, for example, the techniques described in Maniatis et al., 1989 Molecular Cloning A Laboratory Manual, Cold Spring Harbor Laboratory, N.Y., incorporated herein by reference), which distinguishes EBF1 nucleotide sequences, or EBF2 nucleotide sequences.
In another aspect of the invention, very high stringency hybridization conditions can include at least one wash at 0.1×SSC, 0.1% SDS, at 60° C. for 15 minutes. High stringency hybridization conditions can include at least one wash at 0.2×SSC, 0.1% SDS, at 60° C. for 15 minutes. Moderate stringency hybridization conditions can include at least one wash at 0.5×SSC, 0.1% SDS, at 60° C. for 15 minutes. Low stringency hybridization conditions can include at least one wash at 1.0×SSC, 0.1% SDS, at 60° C. for 15 minutes.
Another aspect of the invention is polypeptides or fragments thereof which have at least about 70%, at least about 80%, at least about 85%, at least about 90%, at least about 95%, or more than about 95% homology to SEQ ID NO: 2 or SEQ ID NO: 4, and sequences substantially identical thereto, or a fragment including at least 5, 10, 15, 20, 25, 30, 35, 40, 50, 75, 100, or 150 consecutive amino acids thereof. Homology may be determined using any of the methods described herein which align the polypeptides or fragments being compared and determines the extent of amino acid identity or similarity between them. It will be appreciated that amino acid “homology” includes conservative amino acid substitutions such as those described above.
The polypeptides or fragments having homology to SEQ ID NO: 2, SEQ ID NO: 4, and sequences substantially identical thereto, or a fragment including at least about 5, 10, 15, 20, 25, 30, 35, 40, 50, 75, 100, or 150 consecutive amino acids thereof may be obtained by isolating the nucleic acids encoding them using the techniques described herein.
The homologous polypeptides or fragments may be obtained through biochemical enrichment or purification procedures. The sequence of potentially homologous polypeptides or fragments may be determined by proteolytic digestion, gel electrophoresis and/or microsequencing. The sequence of the prospective homologous polypeptide or fragment can be compared to the polypeptide of SEQ ID NO: 2, SEQ ID NO: 4, and sequences substantially identical thereto, or a fragment including at least about 5, 10, 15, 20, 25, 30, 35, 40, 50, 75, 100, or 150 consecutive amino acids thereof using any of the programs described above.
Also included in embodiments of the invention are nucleotide sequences that are greater than 70% homologous with SEQ ID NO: 1 or SEQ ID NO: 3, but still retain the ability to modulate an aspect of the ethylene response such as germination, flower and leaf senescence, fruit ripening, fruit drop, leaf abscission, root nodulation, programmed cell death, responsiveness to stress, responsiveness to pathogen attack, and the “triple response” of etiolated dicotyledoneous seedlings. Other embodiments of the invention include nucleotide sequences that are greater than 75%, 80%, 85%, 90% or 95% homologous with SEQ ID NO: 1 or SEQ ID NO: 3, but still retain the ability to confer a modulated ethylene response.
SEQ ID NO: 5 includes a polynucleotide encoding EIN3, and SEQ ID NO: 6 includes the corresponding EIN3 protein sequence. This EIN3 protein is a representative member of the EIN3/EIL (EIN3-like) family of transcription factors that is involved in the ethylene response of plants, as described further herein. The EIN3 polynucleotide and protein sequences of SEQ ID NO: 5 and SEQ ID NO: 6 are Arabidopsis sequences. A protein involved in the ethylene response of a plant may be any transcription factor involved in the ethylene response of any plant. In particular, a protein involved in the ethylene response of a plant may be a transcription factor similar to the EIN3/EIL family of transcription factors. In some versions, a transcription factor similar to the EIN3/EIL family of proteins includes a polypeptide or fragment thereof which has at least about 70%, at least about 80%, at least about 85%, at least about 90%, at least about 95%, or more than about 95% homology to SEQ ID NO: 6 and sequences substantially identical thereto, or a fragment including at least 5, 10, 15, 20, 25, 30, 35, 40, 50, 75, 100, or 150 consecutive amino acids thereof. Homology may be determined using any of the alignment methods described herein which align the polypeptides or fragments being compared and determines the extent of amino acid identity or similarity between them. It will be appreciated that amino acid “homology” includes conservative amino acid substitutions such as those described herein.
Examples of orthologs of EIN3 (or other members of the EIN3/EIL family) that are involved in the ethylene response of plants have been found in many plants, including tobacco (e.g., NtEIL1), tomato (e.g., the LeEIL genes), mung bean (e.g., VR-EIL1 and VR-EIL2), and carnation (e.g., DC-EIL). Othologs of EIN3 may be present in other plant types. For example, plants having an ethylene response include, but are not limited to: dicotyledons and monocotyledons including but not limited to rice, maize, wheat, barley, sorghum, millet, grass, oats, tomato, potato, banana, kiwi fruit, avocado, melon, mango, cane, sugar beet, tobacco, papaya, peach, strawberry, raspberry, blackberry, blueberry, lettuce, cabbage, cauliflower, onion, broccoli, brussel sprout, cotton, canola, grape, soybean, oil seed rape, asparagus, beans, carrots, cucumbers, eggplant, melons, okra, parsnips, peanuts, peppers, pineapples, squash, sweet potatoes, rye, cantaloupes, peas, pumpkins, sunflowers, spinach, apples, cherries, plums, cranberries, grapefruit, lemons, limes, nectarines, oranges, peaches, pears, tangelos, tangerines, carnation, chrysanthemum, petunia, rose, geranium, violet, gladioli, orchid, lilac, crabapple, sweetgum tree, maple tree, poinsettia, locust tree, oak tree, ash tree and linden tree. Any of these plants may include a protein involved in the ethylene response of the plant that interacts with protein encoded by an F-box gene. For example, any of these plants may include an EIN3 ortholog.
Specifically disclosed herein are cDNA sequences for EBF1 and EBF2. DNA sequences of the invention can be obtained by several methods. For example, the DNA can be isolated using hybridization or computer-based techniques which are well known in the art. Such techniques include, but are not limited to: 1) hybridization of genomic or cDNA libraries with probes to detect homologous nucleotide sequences; 2) antibody screening of expression libraries to detect cloned DNA fragments with shared structural features; 3) polymerase chain reaction (PCR) on genomic DNA or cDNA using primers capable of annealing to the DNA sequence of interest; 4) computer searches of sequence databases for similar sequences; and 5) differential screening of a subtracted DNA library.
Screening procedures which rely on nucleic acid hybridization make it possible to isolate any gene sequence from any organism, provided the appropriate probe is available. Oligonucleotide probes, which correspond to a part of the sequence encoding the protein in question, can be synthesized chemically. This requires that short, oligopeptide stretches of the amino acid sequence must be known. The DNA sequence encoding the protein can be deduced from the genetic code, however, the degeneracy of the code must be taken into account. It is possible to perform a mixed addition reaction when the sequence is degenerate. This includes a heterogeneous mixture of denatured double-stranded DNA. For such screening, hybridization is preferably performed on either single-stranded DNA or denatured double-stranded DNA. Hybridization is particularly useful in the detection of cDNA clones derived from sources where an extremely low amount of mRNA sequences relating to the polypeptide of interest are present. In other words, by using stringent hybridization conditions directed to avoid non-specific binding, it is possible, for example, to allow the autoradiographic visualization of a specific cDNA clone by the hybridization of the target DNA to that single probe in the mixture which is its complete complement (Wallace, et al., Nucl. Acid Res. 9, 879, 1981). Alternatively, a subtractive library is useful for elimination of non-specific cDNA clones.
Among the standard procedures for isolating cDNA sequences of interest is the formation of plasmid- or phage-carrying cDNA libraries which are derived from reverse transcription of mRNA which is abundant in donor cells that have a high level of genetic expression. When used in combination with polymerase chain reaction technology, even rare expression products can be cloned. In those cases where significant portions of the amino acid sequence of the polypeptide are known, the production of labeled single or double-stranded DNA or RNA probe sequences duplicating a sequence putatively present in the target cDNA may be employed in DNA/DNA hybridization procedures which are carried out on cloned copies of the cDNA which have been denatured into a single-stranded form (Jay, et al. Nucl. Acid Res., 11, 2325, 1983).
A cDNA expression library, such as lamda gt11, can be screened indirectly for EBF peptides (e.g., EBF1 or EBF2) using antibodies specific for EBF1 and/or EBF2. Such antibodies can be either polyclonally or monoclonally derived and used to detect expression product indicative of the presence of EBF1 or EBF2 cDNA.
Another embodiment of the invention relates to plants that have at least one aspect of the ethylene response modulated. Such modifications might include effects on germination, flower and leaf senescence, fruit ripening, leaf abscission, root nodulation, programmed cell death, responsiveness to stress, responsiveness to pathogen attack, and other growth effects. Many of these aspects of the ethylene response have been well characterized. For example, see: U.S. Pat. No. 6,355,778 to Ecker et al.; U.S. Patent Application No. 20040128719 to Klee et al.; Bleecker, A. B. and Kende, H Annu Rev Cell Dev Biol 16, 1-18, 2000; and Johnson, P. R., and Ecker, J. R. Annu Rev Genet, 32, 227-254, 1998. Each of these references is herein incorporated by references in its entirety.
Specific modifications include transgenic plants with an altered ethylene response due to transformation with constructs using antisense or siRNA technology that affect transcription or expression from an F-box gene (or genes) such as EBF1 and/or EBF2. Such plants may have a reduced level of an F-box protein that interacts with a protein involved in the ethylene response of the plant, such as EIN3. Thus, the level of a protein involved in the ethylene response will increase since there may be less of the F-box protein to bind to the protein involved in the ethylene response (and thereby target this protein for degradation). For example, reducing the transcription or expression of EBF1 and/or EBF2 may result in an increase in the level of EIN3 in a plant. Increasing the level of EIN3 may enhance the plant's sensitivity to ethylene.
In addition, specific modifications include transgenic plants with an altered ethylene response due to transformation with constructs using over-expression of one or more F-Box genes that affect transcription or expression from an F-box gene (or genes) such as EBF1 and/or EBF2. Such plants may have a increased level of an F-box protein that interacts with a protein involved in the ethylene response of the plant, such as EIN3. Thus, the level of a protein involved in the ethylene response will decrease since there may be more of the F-box protein to bind to the protein involved in the ethylene response (and thereby target this protein for degradation). For example, increasing the transcription or expression of EBF1 and/or EBF2 may result in a decrease in the level of EIN3 in a plant. Decreasing the level of EIN3 may reduce the plant's sensitivity to ethylene.
Accordingly, in another series of embodiments, the present invention provides methods of screening or identifying proteins, small molecules or other compounds which are capable of inducing or inhibiting the expression of the F-box genes and proteins that interact with a protein involved in the ethylene response of a plant, portion of a plant, or plant cell. The assays may be performed in vitro using transformed or non-transformed cells, immortalized cell lines, or in vivo using transformed plant models enabled herein. In particular, the assays may detect the presence of increased or decreased expression of EBF (e.g., EBF1 and/or EBF2 from Arabidopsis or other plants) genes or proteins on the basis of increased or decreased mRNA expression, increased or decreased levels of EBF protein products, or increased or decreased levels of expression of a marker gene (e.g., beta-galactosidase, green fluorescent protein, alkaline phosphatase or luciferase) operably joined to an EBF 1 or EBF2 5′ regulatory region in a recombinant construct. A plant, portions of a plant, or plant cells known to express a particular EBF, or transformed to express a particular EBF, may be incubated with one or more test compounds (e.g., added to the medium). After allowing a sufficient period of time (e.g., 0-72 hours) for the compound to induce or inhibit the expression of the F-box protein (e.g., EBF1 and/or EBF2), any change in levels of expression from an established baseline may be detected using any of the techniques described above.
In another series of embodiments, the present invention provides methods for identifying proteins and other compounds which bind to, or otherwise directly interact with, F-box proteins that interact with proteins involved in the ethylene response, such as EBF1 and/or EBF2. The proteins and compounds include endogenous cellular components which interact with these F-box proteins in vivo and which, therefore, provide new targets for agricultural products, as well as recombinant, synthetic and otherwise exogenous compounds which may bind an F-box protein (e.g. EBF1 or EBF2) and, therefore, are candidates for modulating the ethylene response (or some aspect of the ethylene response) in a plant. Thus, in one series of embodiments, High Throughput Screening-derived proteins, DNA chip arrays, cell lysates or tissue homogenates may be screened for proteins or other compounds which bind to one of the normal or mutant EBF genes. Alternatively, any of a variety of exogenous compounds, both naturally occurring and/or synthetic (e.g., libraries of small molecules or peptides), may be screened for EBF binding capacity.
Compound sources libraries may be used to screen for compounds that modulate or interact with EBF1, EBF2, and other F-box proteins that interact with proteins involved in the ethylene response. For example, screening with libraries of chemical compounds may be done using commercially available libraries or specially constructed libraries. Such libraries may contain known structures and de novo designs (including enumerated combinatorial libraries). Libraries may be combinatorial libraries, or historical collections of compounds, or may be a combination thereof. Historical collections are typically “targeted” libraries that are derived from classical medicinal chemicals or other known compounds, most of which have very well-defined chemical characteristics. Sources of commercially available compound libraries include: ChemBridge (San Diego, Calif., U.S.A.); Timtec (Wilmington, Del., U.S.A.); Maybridge Ltd. (Cornwall, U.K.); Ryan Scientific (Isle of Palms, S.C., U.S.A.); and CEREP, (Redmond, Wash., U.S.A.).
Virtual screening (also referred to as in silico screening) may be used to identify compounds that modulate EBF1, EBF2, and other F-box proteins of interest. In virtual screening, databases of known structures and new structures (including enumerated combinatorial libraries) are screened against characteristic properties of the target (e.g., EBF1 or EBF2). Commercially available databases that may be employed for virtual screening may be available from: Molecular Design Limited (San Leandro, Calif., U.S.A.); Beilstein Informationssysteme GmbH (Frankfurt, Germany); CSD Systems (Cambridge, UK); Daylight Chemical Information Systems Inc. (C1-aremont, CA, U.S.A.); and Derwent Information (London, U.K.).
In many embodiments, an assay is conducted to detect binding between the F-box protein and another moiety. The F-box protein in these assays may be, for example, EBF1 or EBF2, and may include or derived from a normal or mutant EBF1 or EBF2 protein, including functional domains or antigenic determinants of EBF1 or EBF2. Binding may be detected by non-specific measures (e.g., transcription modulation, altered chromatin structure, peptide production or changes in the expression of other downstream genes which can be monitored by differential display, 2D gel electrophoresis, differential hybridization, or SAGE methods) or by direct measures such as immunoprecipitation, the Biomolecular Interaction Assay (BIAcore) or alteration of protein gel electrophoresis. Some appropriate methods involve variations on the following techniques: (1) direct extraction by affinity chromatography; (2) co-isolation of F-box (e.g., EBF1 or EBF2) components and bound proteins or other compounds by immunoprecipitation; (3) BIAcore analysis; and (4) the yeast two-hybrid systems.
Embodiments of the invention also include methods of identifying proteins, small molecules and other compounds capable of modulating the activity of normal or mutant F-box proteins such as EBF1 and EBF2. The present invention may use normal cells or plants (or portions of plants), the transformed cells and plant models of the present invention, or cells obtained from plants bearing normal or mutant F-box genes. The present invention provides methods of identifying compounds capable of modulating the expression or activity of an F-box gene (e.g., EBF1 or EBF2), and therefore modulating the ethylene response. A compounds may be identified based on the compound's ability to affect the expression of the F-box gene whose product interacts with a protein involved in the ethylene response of a plant; the ability of the F-box gene to interact with a protein involved in the ethylene response of a plant; the activity of other genes regulated by these F-box proteins; the activity of proteins that interact with normal or mutant F-box proteins that interact with a protein involved in the ethylene response of a plant; the intracellular localization of these F-box proteins; changes in transcription activity; changes in ubiquitination; changes in the activity of the ubiquitin/proteosome pathway; or other biochemical, histological, or physiological markers which distinguish cells bearing normal and modulated activity of F-box proteins that interact with proteins involved in the ethylene response in plants.
In accordance with another aspect of the invention, the proteins of the invention can be used as starting points for rational chemical design to provide ligands or other types of small chemical molecules. Alternatively, small molecules or other compounds identified by the above-described screening assays may serve as “lead compounds” in design of modulators of the ethylene response (or aspects of the ethylene response) in plants.
DNA sequences encoding F-box proteins such as EBF1 and EBF2 can be expressed in vitro by DNA transfer into a suitable host cell. “Host cells” are cells in which a vector can be propagated and its DNA expressed. The term also includes any progeny or graft material, for example, of the subject host cell. It is understood that all progeny may not be identical to the parental cell since there may be mutations that occur during replication. However, such progeny are included when the term “host cell” is used. Methods of stable transfer, meaning that the foreign DNA is continuously maintained in the host, are known in the art.
As part of the present invention, the F-box (e.g., EBF1 and/or EBF2) polynucleotide sequences may be inserted into a recombinant expression vector. The terms “recombinant expression vector” or “expression vector” refer to a plasmid, virus or other vehicle known in the art that has been manipulated by insertion or incorporation of the F-box genetic sequence. Such expression vectors contain a promoter sequence which facilitates the efficient transcription of the inserted F-box gene sequence. The expression vector typically contains an origin of replication, a promoter, as well as specific genes which allow phenotypic selection of the transformed cells.
Methods which are well known to those skilled in the art can be used to construct expression vectors containing the EBF1 and/or EBF2 coding sequences and appropriate transcriptional/translational control signals. These methods include in vitro recombinant DNA techniques, synthetic techniques, and in vivo recombination/genetic techniques.
A variety of host-expression vector systems may be utilized to express the EBF1 and/or EBF2 coding sequence. These include but are not limited to microorganisms such as bacteria transformed with recombinant bacteriophage DNA, plasmid DNA or cosmid DNA expression vectors containing the EBF1 and/or EBF2 coding sequence; yeast transformed with recombinant yeast expression vectors containing the EBF1 and/or EBF2 coding sequence; plant cell systems infected with recombinant virus expression vectors (e.g., cauliflower mosaic virus, CaMV; tobacco mosaic virus, TMV) or transformed with recombinant plasmid expression vectors (e.g., Ti plasmid) containing the EBF1 and/or EBF2 coding sequence; insect cell systems infected with recombinant virus expression vectors (e.g., baculovirus) containing the EBF1 and/or EBF2 coding sequence; or animal cell systems infected with recombinant virus expression vectors (e.g., retroviruses, adenovirus, vaccinia virus) containing the EBF1 and/or EBF2 coding sequence, or transformed animal cell systems engineered for stable expression.
Depending on the host/vector system utilized, any of a number of suitable transcription and translation elements, including constitutive and inducible promoters, transcription enhancer elements, transcription terminators, etc. may be used in the expression vector (see e.g., Bitter et al. Methods in Enzymology 153, 516-544, 1987). For example, when cloning in bacterial systems, inducible promoters such as pL of bacteriophage γ, plac, ptrp, ptac (ptrp-lac hybrid promoter) and the like may be used. When cloning in mammalian cell systems, promoters derived from the genome of mammalian cells (e.g., metallothionein promoter) or from mammalian viruses (e.g., the retrovirus long terminal repeat; the adenovirus late promoter; the vaccinia virus 7.5K promoter) may be used. Promoters produced by recombinant DNA or synthetic techniques may also be used to provide for transcription of the inserted EBF1 or EBF2 coding sequence.
Isolation and purification of recombinantly expressed polypeptide, or fragments thereof, may be carried out by conventional means including preparative chromatography and immunological separations involving monoclonal or polyclonal antibodies.
In another embodiment, the invention provides a method for producing a genetically modified plant having at least one modulated aspect of the ethylene response compared to a plant which has not been genetically modified (e.g., a wild-type plant). The method includes the steps of contacting a plant cell with at least one recombinant nucleic acid that alters the expression of an F-box gene. The F-box gene may include, for example, the EBF1 or EBF2 gene, or a mutant, homolog or fragment of EBF1 and/or EBF2. The nucleic acid sequence may be operably associated with a promoter, to obtain a transformed plant cell. A plant may be produced from the transformed plant cell; and thereafter a plant exhibiting a modulated response to ethylene may be selected.
Transgenic plants that result in at least one modulated aspect of the ethylene response may be obtained by reduced expression of the F-box gene. Thus, one embodiment of the invention includes plants transformed with antisense polynucleotides complementary to the EBF 1 and/or EBF2 gene or fragments thereof wherein production of the antisense polynucleotides results in reduced expression of the EBF1 and/or EBF2 gene. In an alternate embodiment, reduced expression of EBF 1 and/or EBF2 may also be achieved by methods such as cosuppression (Hooper, C. J. NIH Res. 3, 49-54, 1991) by operatively linking a truncated form of an F-box gene that interacts with a protein involved in the ethylene response to a promoter.
Transgenic plants that result in at least one modulated aspect of the ethylene response may be obtained by increased expression of the F-box gene. Thus, one embodiment of the invention includes plants transformed with polynucleotides encoding the EBF1 and/or EBF2 gene or fragments thereof wherein production of the polynucleotides results in increased expression of the EBF1 and/or EBF2 gene. Such plants might be expected to display a modulated ethylene response such as ethylene insensitivity.
The term “genetic modification” as used herein refers to the introduction of one or more heterologous nucleic acid sequences, e.g., an EBF1, EBF2, EBF1 mutant, or an EBF2 mutant encoding sequence, into one or more plant cells, which can generate whole, sexually competent, viable plants. The term “genetically modified” as used herein refers to a plant which has been generated through the aforementioned process. Genetically modified plants of the invention are capable of self-pollinating or cross-pollinating with other plants of the same species so that the foreign gene, carried in the germ line, can be inserted into or bred into agriculturally useful plant varieties. The term “plant cell” as used herein refers to protoplasts, gamete producing cells, and cells which regenerate into whole plants. Accordingly, a seed including multiple plant cells capable of regenerating into a whole plant, is included in the definition of “plant cell”.
As used herein, the term “plant” refers to either a whole plant, a plant part, a plant cell, or a group of plant cells, such as plant tissue, for example. Plantlets are also included within the meaning of “plant”. Plants included in the invention are any plants amenable to transformation techniques, including angiosperms, gymnosperms, monocotyledons and dicotyledons.
Examples of monocotyledonous plants include, but are not limited to, asparagus, field and sweet corn, barley, wheat, rice, sorghum, onion, pearl millet, rye and oats. Examples of dicotyledonous plants include, but are not limited to tomato, tobacco, cotton, potato, rapeseed, field beans, soybeans, peppers, lettuce, peas, alfalfa, clover, cole crops or Brassica oleracea (e.g., cabbage, broccoli, cauliflower, brussels sprouts), radish, carrot, beets, eggplant, spinach, cucumber, squash, melons, cantaloupe, sunflowers and various ornamentals. Woody species include poplar, pine, sequoia, cedar, oak, etc.
The term “exogenous nucleic acid sequence” as used herein refers to a nucleic acid foreign to the recipient plant host or, native to the host if the native nucleic acid is substantially modified from its original form. For example, the term includes a nucleic acid originating in the host species, where such sequence is operably linked to a promoter that differs from the natural or wild-type promoter. In one embodiment, at least one nucleic acid sequence encoding the F-box protein (e.g., EBF1 or EBF2) or a variant thereof is operably linked with a promoter. It may be desirable to introduce more than one copy of a polynucleotide into a plant for enhanced expression. For example, introduction of multiple copies of the gene (e.g., the gene encoding an F-box protein that interacts with a protein involved in the ethylene response) would have the increase production of the gene product in the plant. Such a plant would have a reduced sensitivity to ethylene.
Genetically modified plants of the present invention are produced by contacting a plant cell with a recombinant nucleic acid including at least one nucleic acid sequence encoding an F-box protein that interacts with a protein involved in the ethylene response (e.g., EBF1 and/or EBF2) or a variant thereof. To be effective, once introduced into plant cells the nucleic acid sequence may be operably associated with a promoter which is effective in the plant cell to cause transcription of the F-box gene. Additionally, a polyadenylation sequence or transcription control sequence, also recognized in plant cells, may also be employed. It is preferred that the vector harboring the nucleic acid sequence to be inserted also contain one or more selectable marker genes so that the transformed cells can be selected from non-transformed cells in culture, as described herein.
The term “operably linked” refers to a functional linkage between a promoter sequence and a nucleic acid sequence regulated by the promoter. The operably linked promoter controls the expression of the nucleic acid sequence.
The expression of structural genes may be driven by a number of promoters. Although the endogenous, or native promoter of a structural gene of interest may be utilized for transcriptional regulation of the gene, preferably, the promoter is a foreign regulatory sequence. For plant expression vectors, suitable viral promoters include the 35S RNA and 19S RNA promoters of CaMV (Brisson, et al. Nature, 310, 511, 1984; and Odell, et al. Nature, 313, 810, 1985); the full-length transcript promoter from Figwort Mosaic Virus (FMV) (Gowda, et al. J. Cell Biochem. 13D, 301, 1989) and the coat protein promoter to TMV (Takamatsu, et al. EMBO J. 6, 307, 1987). Alternatively, plant promoters such as the light-inducible promoter from the small subunit of ribulose bis-phosphate carboxylase (ssRUBISCO) (Coruzzi, et al. EMBO J. 3, 1671, 1984; and Broglie, et al., Science 224, 838, 1984); mannopine synthase promoter (Velten, et al. EMBO J. 3, 2723, 1984) nopaline synthase (NOS) and octopine synthase (OCS) promoters (carried on tumor-inducing plasmids of Agrobacterium tumefaciens) or heat shock promoters, e.g., soybean hsp17.5-E or hsp17.3-B (Gurley, et al. Mol. Cell. Biol. 6, 559, 1986; and Severin, et al. Plant Mol. Biol. 15, 827, 1990) may be used.
Promoters useful in the invention include both natural constitutive and inducible promoters as well as engineered promoters. Such inducible promoters can be turned on and off. The CaMV promoters are examples of constitutive promoters. To be most useful, an inducible promoter should 1) provide low expression in the absence of the inducer; 2) provide high expression in the presence of the inducer; 3) use an induction scheme that does not interfere with the normal physiology of the plant; and 4) have no effect on the expression of other genes. Examples of inducible promoters useful in plants include those induced by chemical means, such as the yeast metallothionein promoter which is activated by copper ions (Mett, et al. Proc. Natl. Acad. Sci., U.S.A. 90, 4567, 1993); In2-1 and In2-2 regulator sequences which are activated by substituted benzenesulfonamides, e.g., herbicide safeners (Hershey, et al. Plant Mol. Biol. 17, 679, 1991); and the GRE regulatory sequences which are induced by glucocorticoids (Schena, et al. Proc. Natl. Acad. Sci., U.S.A. 88, 10421, 1991). Other promoters, both constitutive and inducible will be known to those of skill in the art.
The particular promoter selected should be capable of causing sufficient expression to result in the production of an effective amount of gene product to modulate the ethylene response of a plant. The promoters used in the vector constructs of the present invention may be modified, if desired, to affect their control characteristics.
Tissue specific promoters may also be utilized in the present invention. An example of a tissue specific promoter is the promoter active in shoot meristems (Atanassova, et al. Plant J. 2, 291, 1992). Other tissue specific promoters useful in transgenic plants, including the cdc2a promoter and cyc07 promoter, will be known to those of skill in the art. (See for example, Ito, et al. Plant Mol. Biol. 24, 863, 1994; Martinez, et al. Proc. Natl. Acad. Sci. USA 89, 7360, 1992; Medford, et al. Plant Cell 3, 359, 1991; Terada, et al. Plant Journal 3, 241, 1993; Wissenbach, et al. Plant Journal 4, 411, 1993).
Optionally, a selectable marker may be associated with the nucleic acid sequence to be inserted. As used herein, the term “marker” refers to a gene encoding a trait or a phenotype which permits the selection of, or the screening for, a plant or plant cell containing the marker. Preferably, the marker gene is an antibiotic resistance gene whereby the appropriate antibiotic can be used to select for transformed cells from among cells that are not transformed. Examples of suitable selectable markers include adenosine deaminase, dihydrofolate reductase, hygromycin-B-phospho-transferase, thymidine kinase, xanthine-guanine phospho-ribosyltransferase and amino-glycoside 3′-O-phospho-transferase II (kanamycin, neomycin and G418 resistance). Other suitable markers will be known to those of skill in the art.
Vector(s) employed in the present invention for transformation of a plant cell include a nucleic acid sequence encoding an F-box gene (e.g., EBF1 and/or EBF2), operably linked to a promoter. To commence a transformation process in accordance with the present invention, it is first necessary to construct a suitable vector and properly introduce it into the plant cell. Details of the construction of vectors utilized herein are known to those skilled in the art of plant genetic engineering.
The nucleic acid sequences utilized in the present invention can be introduced into plant cells using Ti plasmids of Agrobacterium tumefaciens, root-inducing (R1) plasmids, and plant virus vectors. (For reviews of such techniques see, for example, Weissbach & Weissbach, Methods for Plant Molecular Biology, Academic Press, NY, Section VIII, pp. 421-463, 1988; and Grierson & Corey, Plant Molecular Biology, 2d Ed., Blackie, London, Ch. 7-9, 1998; and Horsch, et al. Science, 227, 1229, 1985, both incorporated herein by reference). In addition to plant transformation vectors derived from the Ti or root-inducing (R1) plasmids of Agrobacterium, alternative methods may involve, for example, the use of liposomes, electroporation, chemicals that increase free DNA uptake, transformation using viruses or pollen and the use of microprojection.
One of skill in the art will be able to select an appropriate vector for introducing the F-box-encoding nucleic acid sequence in a relatively intact state. Thus, any vector which will produce a plant carrying the introduced DNA sequence should be sufficient. Even use of a naked piece of DNA would be expected to confer the properties of this invention, though at low efficiency. The selection of the vector, or whether to use a vector, is typically guided by the method of transformation selected.
The transformation of plants in accordance with the invention may be carried out in essentially any of the various ways known to those skilled in the art of plant molecular biology. (See, for example, Methods of Enzymology, Vol. 153, 1987, Wu and Grossman, Eds., Academic Press, incorporated herein by reference). As used herein, the term “transformation” means alteration of the genotype of a host plant by the introduction of an F-box gene or a mutant F-box nucleic acid sequence.
For example, an EBR1 and/or an EBF2 nucleic acid sequence can be introduced into a plant cell utilizing Agrobacterium tumefaciens containing the Ti plasmid, as mentioned briefly above. In using an A. tumefaciens culture as a transformation vehicle, it is most advantageous to use a non-oncogenic strain of Agrobacterium as the vector carrier so that normal non-oncogenic differentiation of the transformed tissues is possible. It is also preferred that the Agrobacterium harbor a binary Ti plasmid system. Such a binary system includes 1) a first Ti plasmid having a virulence region essential for the introduction of transfer DNA (T-DNA) into plants, and 2) a chimeric plasmid. The latter contains at least one border region of the T-DNA region of a wild-type Ti plasmid flanking the nucleic acid to be transferred. Binary Ti plasmid systems have been shown effective to transform plant cells (De Framond, Biotechnology, 1, 262, 1983; Hoekema, et al., Nature, 303, 179, 1983). Such a binary system is preferred because it does not require integration into the Ti plasmid of Agrobacterium.
Methods involving the use of Agrobacterium in transformation according to the present invention include, but are not limited to: 1) co-cultivation of Agrobacterium with cultured isolated protoplasts; 2) transformation of plant cells or tissues with Agrobacterium; or 3) transformation of seeds, apices or meristems with Agrobacterium.
In addition, gene transfer can be accomplished by in planta transformation by Agrobacterium, as described by Bechtold, et al., (C. R. Acad. Sci. Paris, 316:1194, 1993). This approach is based on the vacuum infiltration of a suspension of Agrobacterium cells.
One method of introducing F-box-encoding nucleic acid (e.g., EBF1 and/or EBF2) into plant cells is to infect such plant cells, an explant, a meristem or a seed, with transformed Agrobacterium tumefaciens as described above. Under appropriate conditions known in the art, the transformed plant cells are grown to form shoots, roots, and develop further into plants.
Alternatively, nucleic acid sequences can be introduced into a plant cell using mechanical or chemical means. For example, the nucleic acid can be mechanically transferred into the plant cell by microinjection using a micropipette. Alternatively, the nucleic acid may be transferred into the plant cell by using polyethylene glycol which forms a precipitation complex with genetic material that is taken up by the cell.
Nucleic acid sequences can also be introduced into plant cells by electroporation (Fromm, et al., Proc. Natl. Acad. Sci., U.S.A., 82:5824, 1985, which is incorporated herein by reference). In this technique, plant protoplasts are electroporated in the presence of vectors or nucleic acids containing the relevant nucleic acid sequences. Electrical impulses of high field strength reversibly permeabilize membranes allowing the introduction of nucleic acids. Electroporated plant protoplasts reform the cell wall, divide and form a plant callus. Selection of the transformed plant cells with the transformed gene can be accomplished using phenotypic markers as described herein.
Another method for introducing nucleic acid into a plant cell is high velocity ballistic penetration by small particles with the nucleic acid to be introduced contained either within the matrix of such particles, or on the surface thereof (Klein, et al., Nature 327:70, 1987). Bombardment transformation methods are also described in Sanford, et al. (Techniques 3:3-16, 1991) and Klein, et al. (Bio/Techniques 10:286, 1992). Although, typically only a single introduction of a new nucleic acid sequence is required, this method particularly provides for multiple introductions.
Cauliflower mosaic virus (CaMV) may also be used as a vector for introducing nucleic acid into plant cells (U.S. Pat. No. 4,407,956). CaMV viral DNA genome is inserted into a parent bacterial plasmid creating a recombinant DNA molecule which can be propagated in bacteria. After cloning, the recombinant plasmid again may be cloned and further modified by introduction of the desired nucleic acid sequence. The modified viral portion of the recombinant plasmid is then excised from the parent bacterial plasmid, and used to inoculate the plant cells or plants.
As used herein, the term “contacting” refers to any means of introducing nucleic acid material into the plant cell, including chemical and physical means as described above. Preferably, contacting refers to introducing the nucleic acid or vector into plant cells (including an explant, a meristem or a seed), via Agrobacterium tumefaciens transformed with the encoding nucleic acid as described above.
Normally, a plant cell is regenerated to obtain a whole plant from the transformation process. The immediate product of the transformation is referred to as a “transgenote”. The term “growing” or “regeneration” as used herein means growing a whole plant from a plant cell, a group of plant cells, a plant part (including seeds), or a plant piece (e.g., from a protoplast, callus, or tissue part).
Regeneration from protoplasts varies from species to species of plants, but generally a suspension of protoplasts is first made. In certain species, embryo formation can then be induced from the protoplast suspension, to the stage of ripening and germination as natural embryos. The culture media will generally contain various amino acids and hormones, necessary for growth and regeneration. Examples of hormones utilized include auxins and cytokinins. It is sometimes advantageous to add glutamic acid and proline to the medium, especially for plant species such as corn and alfalfa. Efficient regeneration will depend on the medium, on the genotype, and on the history of the culture. If these variables are controlled, regeneration is reproducible.
Regeneration also occurs from plant callus, explants, organs or parts. Transformation can be performed in the context of organ or plant part regeneration. (see Methods in Enzymology, Vol. 118 and Klee, et al., Annual Review of Plant Physiology, 38:467, 1987). Utilizing the leaf disk-transformation-regeneration method of Horsch, et al., Science, 227:1229, 1985, disks are cultured on selective media, followed by shoot formation in about 2-4 weeks. Shoots that develop are excised from calli and transplanted to appropriate root-inducing selective medium. Rooted plantlets are transplanted to soil as soon as possible after roots appear. The plantlets can be repotted as required, until reaching maturity.
In vegetatively propagated crops, the mature transgenic plants are propagated by utilizing cuttings or tissue culture techniques to produce multiple identical plants. Selection of desirable transgenotes is made and new varieties are obtained and propagated vegetatively for commercial use.
In seed propagated crops, the mature transgenic plants can be self crossed to produce a homozygous inbred plant. The resulting inbred plant produces seed containing the newly introduced foreign gene(s). These seeds can be grown to produce plants that would produce the selected phenotype, e.g. altered time to flowering.
Parts obtained from regenerated plant, such as flowers, seeds, leaves, branches, roots, fruit, and the like are included in the invention, provided that these parts include cells that have been transformed as described. Progeny and variants, and mutants of the regenerated plants are also included within the scope of the invention, provided that these parts include the introduced nucleic acid sequences.
Plants exhibiting a modulated ethylene response such (e.g., the “triple response” of etiolated dicotyledoneous seedlings) as compared with wild-type plants can be selected by visual observation. The invention includes plants produced by the method of the invention, as well as plant tissue and seeds. Stem shape and size may be observed visually or preferably may be determined quantitatively by measuring with a ruler or with a video-imaging system. Fruit drop can be measured before and after treatment. Sugar content of ripening fruit. Enzymes levels can be moderated.
In yet another embodiment, the invention provides a method for producing a genetically modified plant cell such that a plant produced from the cell has a modulated ethylene sensitivity compared with a wild-type plant. The method includes contacting the plant cell with an nucleic acid sequence that alters the expression of an F-box gene, wherein the F-box gene encodes a first protein that interacts with a second protein involved in the ethylene response of the plant, to obtain a transformed plant cell. The method may also include growing the transformed plant cell under plant forming conditions to obtain a plant having a modulated ethylene response. Conditions such as environmental and promoter inducing conditions vary from species to species, but should be the same within a species.
The ubiquitin/proteasome pathway of protein degradation is typically controlled by the ubiquitin-ligating SCF (SKP1/Cullin/F-box protein) complex. The F-box proteins confer substrate specificity to the SCF complex and the ubiquitin/proteasome pathway. F-box proteins mediate substrate selectivity by binding to the target protein that will later be degraded by the proteasome.
In Arabidopsis, over 1000 F-box motif-containing proteins have been identified. Members of the F-box protein family typically contain a conserved 40-50 amino acid F-box motif. The lack of a strict consensus may make identification by eye difficult, therefore it may be necessary to use search algorithms to detect F-boxes. F-box proteins may also include motifs capable of protein-protein interaction, which may recruit specific substrates to the SCF complex.
The SCF complex was first identified in yeast and includes four subunits: Skp1, Cullin, Roc1/Rbx1/Hrt1 and an F-box protein. The first three proteins form a common scaffold onto which different F-box proteins can be assembled. The F-box protein may confer specificity to the SCF complex. SCF complexes may be designated by their associated F-box protein, for example, SCFEBF1 and SCFEBF2. The F-box motif may interact with the Skp 1 component. ASK1 is the Arabidopsis ortholog of the SKP protein.
As described herein, F-box proteins may interact (e.g., by targeting for degredation) with proteins involved in the ethylene response. In particular, a subset of F-box proteins, called EBF (“EIN3 binding F-box”) proteins, may interact with the transcription factor EIN3, and related proteins (e.g., homologs, orthologs, etc.). Although two particular F-box proteins, ERB1 and ERB2 are characterized here, additional F-box proteins, including additional EBF proteins, are intended to be within the scope of this invention.
It will be understood by those of skill in the art that numerous and various modifications can be made without departing from the spirit of the present invention. A more complete understanding can be obtained by reference to the following specific examples which are provided herein for purposes of illustration only and are not intended to limit the scope of the invention.
EIN3 is a key transcription factor positively regulating gene expression in response to ethylene. We sought to investigate how EIN3 is regulated by ethylene. Overexpression of EIN3 (EIN3ox) in transgenic plants results in constitutive ethylene responses, implying that EIN3 abundance is important for its function. However, previous studies revealed that the level of EIN3 RNA is not altered either by ethylene treatment, or in the ein2 or ctr1 mutant, suggesting a post-transcriptional mechanism on EIN3 regulation by ethylene. To determine whether the level of EIN3 protein is subject to ethylene regulation, we first monitored the levels of EIN3 protein in wild-type plants grown in growth medium supplemented with various concentrations of ACC, an ethylene biosynthetic precursor. As shown in
Genetic studies have identified several components of the ethylene signaling pathway, including the ETR/ERS family of receptors, CTR1, EIN2, EIN5, and EIN6 (Stepanova and Ecker, 2000). We asked whether any of these signaling components are required for ethylene-induced EIN3 accumulation. Silver ion is a potent inhibitor of ethylene action that acts by interfering with ethylene perception (Abeles et al., Ethylene in Plant Biology, Second Edition, 1992). We tested whether silver treatment perturbs EIN3 accumulation upon ethylene treatment. As shown in
In contrast to the ethylene-insensitive mutants, the ctr1 and eto mutants display constitutively activated ethylene responses (Kieber et al., Cell 72, 427-441 1993). Consistent with its phenotype, ctr1 expressed a higher level of EIN3 in comparison with wild type when no exogenous ethylene was applied (
As the level of EIN3 is low in the absence of ethylene, we asked whether EIN3 protein is unstable in this condition. After boosting EIN3 levels in wild-type seedlings by ethylene treatment, seedlings were placed in a stream of hydrocarbon-free air and level of EIN3 protein was monitored. As shown in
We next examined how ethylene evokes EIN3 protein accumulation. The rapid increase in EIN3 protein accumulation upon ethylene treatment could be attributed either to ethylene-induced de novo protein synthesis, or to ethylene-directed repression of constitutive EIN3 protein turnover, or to a combination of both processes. To address this issue, we blocked de novo translation initiation using cyclohexamide (CHX) and compared the levels of EIN3 protein in the presence or absence of ethylene. After 2 hr of hormone treatment, seedlings were incubated with CHX and kept in either ethylene or hydrocarbon-free air. As shown in
The ubiquitin/proteasome pathway is involved in the rapid degradation of many short-lived proteins that regulates numerous cellular processes (Hochstrasser, Annu Rev Genet. 30, 405-439, 1996). Because EIN3 turnover is rapid, we speculated that a proteasome-mediated pathway might be responsible for its degradation. To test this possibility, we treated Arabidopsis suspension cell cultures with proteasome-specific inhibitors, MG132 and MG115 (Lee and Goldberg, Trends Cell Biol 8, 397-403, 1998). After 30 min of MG132 treatment, the levels of EIN3 protein markedly increased (
EIN3 is localized in the nucleus in transiently transformed protoplast cells (Chao et al., Cell 89, 1133-1144, 1997). To assess whether the nuclear localization of EIN3 is modulated by ethylene, we made transgenic Arabidopsis plants that express an EIN3-GFP fusion protein driven by the constitutive CaMV 35S promoter. Overexpression of EIN3-GFP was able to complement the ein3 mutant (data not shown), indicating that this fusion protein was functional in plants. Immunoblot analysis indicated that the level of EIN3-GFP fusion protein was dramatically increased by ethylene (
Several F-box proteins have recently been identified as key regulators of plant hormone signaling pathways (Frugis and Chua, Trends Cell Biol 12, 308-311, 2002; Vierstra, Trends Plant Sci 8, 135-142, 2003). Because EIN3 abundance is regulated by a proteasome-dependent pathway, we speculated that one or more specific F-box proteins would mediate the EIN3 degradation process. While there are approximately 700 putative F-box proteins in the Arabidopsis genome, only a few of them have been functionally characterized (Gagne et al., Proc Natl Acad Sci 99, 11519-11524, 2002). Using the EIN3 N-terminal domain as bait in yeast two-hybrid screen, we failed to identify any F-box protein that could interact with EIN3. We then directly tested the possible interaction between EIN3 full-length protein and individual F-box proteins. Using genome-wide microarray experiments, we narrowed the search for EIN3-interacting F-box proteins by first testing those genes whose RNA levels were regulated by ethylene (Alonso et al., Science 301, 653-657, 2003; H. G. and J. R. E., unpublished data). From this gene list, two closely related candidate F-box proteins were identified which were able to interact with EIN3 in yeast two-hybrid assays (
To investigate the biological relevance of EBF 1 and EBF2 in EIN3 regulation, we isolated mutants that harbor T-DNA insertion mutations in the two F-box genes. Two homozygous ebf1 mutants (ebf1-1, ebf1-2) and one homozygous ebf2 mutant (ebf2-1) were obtained (see Example 9, below). Each of these mutants contained a T-DNA insertion located within the LRR-encoding region (
To test the genetic interaction of ebf1 and ebf2 mutants, we generated ebf1 ebf2 double mutant plants. ebf1 ebf2 etiolated seedlings showed a pronounced triple response phenotypes in the absence of exogenous ethylene (
To test whether the ethylene hypersensitivity caused by ebf1 and ebf2 mutations is the consequence of enhanced EIN3 stability, we generated double mutants between ein3 and ebf1 or ebf2. As shown in
To further define the function of EBF1 and EBF2 in the ethylene signaling pathway, we constructed transgenic plants containing either F-box gene under the control of the CaMV 35S promoter, allowing constitutive high-level (5- to 20-fold increase) expression of RNAs for each of these genes (data not shown). As exemplified by an elongated hypocotyl and opened hypocotyl hook, overexpression of EBF 1 caused partial insensitivity to ethylene, especially in aerial tissues (
EIN3 is a plant-specific DNA-binding protein that is both necessary and sufficient for the activation of all known ethylene responses. Here, we show that EIN3 accumulation is regulated by ethylene gas at the protein level, and identify two new genes (and their corresponding mutants) that function as negative regulators in the ethylene signaling pathway. Several lines of evidence indicate that the level of EIN3 protein directly reflects the strength of the ethylene signal, and regulation of EIN3 abundance is a rate-limiting step in the ethylene response pathway. First, the extent of ethylene response arising from different concentrations of ACC is positively correlated with the abundance of EIN3 protein. Second, the level of EIN3 protein is induced by ethylene, and the kinetics of EIN3 induction are comparable with those of the induction of ethylene-responsive genes (e.g. ERF1) (Solano et al., Genes Dev 12, 3703-3714, 1998). Third, elevated EIN3 levels in transgenic plants (EIN3ox) result in a constitutive triple response (Chao et al., Cell 89, 1133-1144, 1997). Moreover, the level of EIN3ox protein can be further escalated by ethylene treatment, which consequently leads to even greater ethylene response phenotypes. Fourth, all ethylene-insensitive mutants that we examined are impaired in the accumulation of EIN3 protein. Likewise, treatment with silver ion, a potent inhibitor of ethylene action, abolishes EIN3 accumulation. On the other hand, in the ctr1 and eto mutants, which display constitutive ethylene response (Guzman and Ecker, Plant Cell 2, 513-523, 1990; Kieber et al., Cell 72, 427-441, 1993), steady state EIN3 levels are greater than that of wild type in the absence of ethylene. Fifth, inhibition of EIN3 proteolysis by mutations in the EBF1/EBF2 genes increases EIN3 accumulation and consequently results in enhanced ethylene responses. Last, promotion of EIN3 degradation by overexpression of EBF1/EBF2 leads to reduced EIN3 abundance and thereby partial ethylene insensitivity.
Genetic and molecular studies have unraveled a linear ethylene signal transduction pathway, in which EIN3 acts downstream of the ETR/ERS receptors, CTR1 and EIN2. Consistent with this notion, our biochemical studies show that ETR1, EIN4, CTR1, and EIN2 are all required for the regulation of EIN3 accumulation. In addition, we show that EIN5 and EIN6, whose positions in the ethylene signaling pathway were previously obscure, are also required for EIN3 accumulation in response to ethylene. These results thus establish that both EIN5 and EIN6 act upstream of EIN3. With the notable exception of ein2 null mutants, EIN3 can accumulate to some extent after long exposure to ethylene in all other ethylene insensitive mutants examined (etr1, ein4, ein5, ein6), suggesting that the ethylene signaling is not completely blocked in these plants. Furthermore, the level of EIN3 remains weakly responsive to ethylene in ctr1-1 mutants, although an elevated basal level is observed in ctr1-1 in the absence of ethylene. As ctr1-1 was shown to be a null mutation (Huang et al., Plant J 33, 221-233, 2003), these results suggest the existence of a CTR1-independent response, which adds a new dimension to the linear ethylene pathway. This is consistent with the observation that ctr1 seedlings respond to ethylene treatment (Larsen and Chang, Plant Physiol 125, 1061-1073, 2001).
In the absence of ethylene, EIN3 is an unstable protein with a half-life shorter than 30 minutes. Several short-lived proteins are subject to proteasome-mediated protein degradation process in both animals and plants (Hellmann and Estelle, Science 297, 793-797, 2002; Hochstrasser, Annu Rev Genet. 30, 405-439, 1996). For instance, AUX/IAA proteins, a group of transcriptional repressors in auxin signaling, are degraded through an ubiquitin/proteasome pathway (Gray et al., Nature 414, 271-276, 2001). Similarly, RGA/GAI/SLN proteins, negative components of the GA signaling pathway, are destroyed by an ubiquitin/proteasome pathway (Sasaki et al., Science 299, 1896-1898, 2003; McGinnis et al., Plant Cell 15, 1120-1130, 2003). Here, we demonstrate that EIN3 transcription factor, a positive regulator in the ethylene signaling pathway, is targeted by the ubiquitin/proteasome pathway for degradation. Both endogenous and transgenically overexpressed EIN3 or an EIN3-GFP fusion protein can be stabilized by treatment with proteasome inhibitors (MG132 and MG115), as well as by ethylene treatment. In addition to increasing abundance, exposure to ethylene and MG132 treatment leads to nuclear localization of EIN3 protein. Thus, inhibition of proteasome function is reminiscent of the effects of exogenous ethylene treatment on EIN3 regulation, suggesting that ethylene induces EIN3 accumulation in the nucleus by interfering with the proteasome-mediated EIN3 degradation process. One possibility is that ethylene inhibits the function of proteolytic machinery that specifically targets EIN3 for destruction. Alternatively, ethylene might modulate EIN3 in a post-translational manner so that EIN3 becomes less accessible or more resistant to the degradation process. It is well known that ubiquitination of a target protein is often preceded by protein phosphorylation. As many ethylene signaling components are protein kinases (Gamble et al., Proc Natl Acad Sci 95, 7825-7829, 1998; Huang et al., Plant J33, 221-233, 2003; Ouaked et al., Embo J 22, 1282-1288, 2003), it is conceivable that EIN3 may be phosphorylated, which could trigger EIN3 ubiquitination/degradation.
We have identified two F-box proteins (EBF1 and EBF2) that interact with EIN3, and demonstrated the involvement of these two proteins in EIN3 regulation as well as in the ethylene response pathway. Loss-of-function mutations in the two F-box genes (ebf1 and ebf2) resulted in increased EIN3 accumulation, and consequently, enhanced response to ethylene. ebf1 ebf2 double mutants showed a wide range of ctr 1-like phenotypes including the constitutive triple response in etiolated seedlings, protruding gynoecium, small size rosette and dwarfism in adult plants. Genetic studies revealed that ein3 suppresses the monogenic ebf1 and ebf2 mutants (this study) as well as the ebf1 ebf2 double mutants (Potuschak et al., Cell, 115(6), 679-89, 2003), indicating that the function of these two F-box proteins is dependent upon the presence of EIN3. Moreover, transgenic overexpression of either F-box gene leads to reduced EIN3 abundance and a corresponding decrease in sensitivity to ethylene. While monogenic ebf1 and ebf2 mutants slightly suppress ein2 (this study), ebf1 ebf2 double mutant plants show strong suppression (or bypass) of ein2 (Potuschak et al., Cell, 115(6), 679-89, 2003), suggesting that EBF1/EBF2 acts downstream of or parallel with EIN2. Together, these results demonstrate that EBF1 and EBF2 play a negatively regulatory role in the ethylene signaling pathway by targeting EIN3 for degradation.
Based on these results, we propose a model for EIN3 regulation by ethylene (
This study reveals that the gaseous hormone ethylene exerts its effect on plant growth by controlling the abundance of EIN3 transcription factor. In addition, a link has been established between the ethylene signaling pathway and the ubiquitin/proteasome pathway, which has recently become the paradigm for plant hormone signaling. A ubiquitin/proteasome pathway has been demonstrated in auxin, GA, and JA signaling, and implicated in the ABA, SA, cytokinin, and brassinosteroid responses (reviewed by Frugis and Chua, Trends Cell Biol 12, 308-311, 2002; Vierstra, Trends Plant Sci 8, 135-142, 2003). It is worth noting that the ubiquitin/proteasome pathway positively regulates the auxin, GA, and JA signaling pathway by targeting negative regulators for degradation (Gray et al., Genes Dev 13, 1678-1691, 1999; Sasaki et al., Science 299, 1896-1898, 2003; Xie et al., 1998). The corresponding hormone acts to promote the repressors' degradation. In contrast, the ubiquitin/proteasome pathway mediated by EBF1/EBF2 negatively regulates the ethylene signaling pathway by targeting EIN3 transcription factor for degradation. Ethylene acts to stabilize EIN3 protein by preventing its degradation process. A similar regulatory mechanism might also occur in the ABA signaling pathway, mediated by the bZIP transcription factor ABI5 (Lopez-Molina et al., Proc Natl Acad Sci 98, 4782-4787, 2001), and in the brassinosteroid signaling pathway, mediated by two nuclear proteins BES1/BZR1 (He et al., Proc Natl Acad Sci 99, 10185-10190, 2002; Yin et al., Cell 109, 181-191, 2002). In both of these cases, the corresponding hormone has been shown to alter the stability of these positive regulators, although no F-box proteins or other SCF components have been identified that target these proteins for degradation. In this regard, ethylene is able to trigger an EIN3-mediated response rapidly by blocking protein turnover, rather than by initiating the more time-consuming route of de novo transcription/translation. This “jump-start” feature of the ethylene response pathway might be vital for the role of ethylene as an endogenous stress hormone, especially in the rapid response to wounding or various plant pathogens.
With the exception of eto2 in Landsberg erecta (Ler) background, the ecotype Columbia (Col-0) was the parent strain for all mutant and transgenic lines described herein. Arabidopsis seeds were surface-sterilized and plated on the surface of MS medium (4.3 g MS salts, 10 g sucrose, pH 5.7, 8 g bactoagar per liter). After 3-4 days in the light at 4° C., the plates were wrapped in foil and kept in a 24° C. incubator before the phenotypes of seedlings were analyzed. For propagation, seedlings from plates were transferred to soil (Promix-HP) and grown to maturity at 22° C. under a 16 hr light/8 hr dark cycle.
Ethylene treatment of Arabidopsis seedlings grown on plates was performed in containers by flowing through hydrocarbon-free air supplemented with 10 ppm (parts per million) ethylene or were treated with hydrocarbon-free air alone (Kieber et al., Cell 72, 427-441, 1993). For drug treatments, Arabidopsis suspension cell cultures were treated with MG132 (50 μM), MG115 (50 μM), Pefabloc SC (100 μM) or DMSO (0.1%) for a time course study. Alternatively, etiolated seedlings were germinated for three days on a disc of Whatman paper resting on the surface of MS medium. MG132 (50 μM), MG115 (50 μM), Pefabloc SC (100 μM) or DMSO (0.1%) was added to the paper discs for 4 hr. Cycloheximide (100 μM) was added to the paper discs and ethylene or air was applied for different amounts of time.
Total RNA extractions and northern blot analysis were performed as described (Chao et al., Cell 89, 1133-1144, 1997).
The coding region corresponding to residues 349 to 581 of EIN3 protein was PCR-amplified, expressed, purified from E. coli, and used to raise polyclonal antibodies in rabbits. Immunoblot assays were performed as described (Lin et al., Proc Natl Acad Sci 92, 8423-8427, 1995) with minor modifications. Protein samples were prepared by homogenizing the powdered tissues in 2×SDS-PAGE sample buffer and boiling the homogenate for 5 min. After centrifugation, the protein extracts were fractionated by 4-12% gradient Tris-Glycine Novex precast gels (Invitrogen), blotted onto a nitrocellulose filter. The blot was probed first with anti-EIN3 antibody, and was subsequently stripped with 0.2 N glycine (pH 2.5) for 3 times and re-probed with either anti-CRY1 antibody (Lin et al., Proc Natl Acad Sci 92, 8423-8427, 1995) or anti-SUB I antibody (Guo et al., Science 291, 487-490, 2001)
The cDNA sequences of the EIN3, ASK1, F-box genes and their derivatives were cloned into pAS2 or pACT2 vector (Clontech). Yeast transformation, growth conditions, and filter-lift assays for β-galactosidase activity were performed according to the manufacturer's instructions (Clontech).
To identify knockouts in the EBF1 and EBF2 genes, we first searched the database of Salk T-DNA collections (Alonso et al., Science 301, 653-657, 2003) and identified one mutant line, ebf1-1. We next screened a pooled genomic DNA collection containing approximately 80,000 T-DNA tagged lines by a PCR-based method (Alonso and Ecker, unpublished) and two additional mutants (ebf1-2 and ebf1-1) were identified. Plants homozygous for the insertions were identified by PCR-based genotyping. Co-segregation between phenotype of ebf1 or ebf1 mutant and the corresponding T-DNA insertion was established in the segregation population of backcross lines. Double mutants were constructed by genetic crosses and homozygous lines were identified by PCR-based genotyping.
EIN3 cDNA was cloned into the binary vector CHF3-GFP (Yin et al., Cell 109, 181-191, 2002). The resulting 35S::EIN3-GFP construct was introduced into Agrobacterium strain C58 and subsequently transformed into Arabidopsis wild-type (Col-0) and ein3-1 plants (Bechtold and Pelletier, Methods Mol. Biol. 82, 259-66, 1998). Kanamycin-resistant T1 plants were selected by plating seeds on MS medium supplemented with 1% sucrose and 50 μg/ml Kanamycin. The triple response phenotype was scored in T2 seedlings originated from individual Kanamycin-resistant T1 plants. Transgenic seedlings that expressed a functional EIN3-GFP fusion protein were mounted on glass slides using PBS as a mounting medium. All images were collected on a fluorescence microscope (Olympus BX60) and the color of the images was artificially added in Photoshop 5.0 (Adobe Systems). For the time course experiment, after the first cell image was taken, 50 μM of ACC or MG132 was applied to the slide and the same cell was followed for 4 hr.
The binary vector pKYLX7 was modified by inserting a loxP site in the MCS region (Li and Ecker, unpublished). The EBF1 and EBF2 full-length cDNA sequences were cloned into pUNI15 vector at Nde I/Bam HI site (a gift from Dr. Stephen Elledge). An in vitro plasmid fusion reaction, catalyzed by Cre recombinase, was carried out between pUNI15 (containing F-box cDNA sequence) and the modified pKYLX7. The resulting constructs that harbor the F-box coding regions driven by CaMV 35S promoter were introduced into Agrobacterium strain C58 and subsequently transformed into Arabidopsis plants. Transgenic T1 plants were identified by Kanamycin selection. The triple response phenotype was scored in T2 seedlings originated from individual transgenic T1 plants. Homozygous T3 seedlings were subjected to ethylene treatment and immunoblot assays.
The following references are hereby incorporated by reference in their entirety.
Roman, G., Lubarsky, B., Kieber, J. J., Rothenberg, M., and Ecker, J. R. (1995). Genetic analysis of ethylene signal transduction in Arabidopsis thaliana: five novel mutant loci integrated into a stress response pathway. Genetics 139, 1393-1409.
Arabidopsis thaliana unknown protein At2g2549 )
Arabidopsis thaliana thale cress)
Arabidopsis thaliana unknown protein At2g2549 )
Arabidopsis thaliana thale cress)
Arabidopsis thaliana EIN3-binding F-box protein 2 EBF2)
Arabidopsis thaliana thale cress)
Arabidopsis thaliana EIN3-binding F-box protein 2 EBF2)
Arabidopsis thaliana thale cress)
Arabidopsis thaliana ethylene-insensitive 3 EIN3) At3g2
Arabidopsis thaliana thale cress)
Arabidopsis thaliana ethylene-insensitive 3 EIN3) At3g2
Arabidopsis thaliana thale cress)
This application is a divisional of U.S. application Ser. No. 11/298,286, filed Dec. 9, 2005, which claims the benefit of U.S. Provisional Application No. 60/635,121, filed Dec. 10, 2004, which is hereby incorporated by reference in its entirety.
This invention was made with United States Government Support under Grant No. 1F32GM66639 from the National Institute of Health, Grant No. MCB-0213154 from the National Science Foundation, and Grant No. DE-FG03-00 ER15113 from the Department of Energy. The United States Government has certain rights in this invention.
| Number | Date | Country | |
|---|---|---|---|
| 60635121 | Dec 2004 | US |
| Number | Date | Country | |
|---|---|---|---|
| Parent | 11298286 | Dec 2005 | US |
| Child | 12643033 | US |
